166 related articles for article (PubMed ID: 22038495)
1. Acute myocardial infarction in streptozotocin-induced hyperglycaemic rats: protection by a carbon monoxide-releasing molecule (CORM-3).
Filippo CD; Perretti M; Rossi F; Ferraraccio F; Motterlini R; D'Amico M
Naunyn Schmiedebergs Arch Pharmacol; 2012 Feb; 385(2):137-44. PubMed ID: 22038495
[TBL] [Abstract][Full Text] [Related]
2. Carbon Monoxide Releasing Molecule A1 Reduces Myocardial Damage After Acute Myocardial Infarction in a Porcine Model.
Iqbal J; Chamberlain J; Alfaidi M; Hughes M; Alizadeh T; Casbolt H; Evans P; Mann B; Motterlini R; Francis S; Gunn J
J Cardiovasc Pharmacol; 2021 Nov; 78(5):e656-e661. PubMed ID: 34328710
[TBL] [Abstract][Full Text] [Related]
3. Evaluating the effects of carbon monoxide releasing molecule-2 against myocardial ischemia-reperfusion injury in ovariectomized female rats.
Kumar A; Boovarahan SR; Prem PN; Ramanathan M; Chellappan DR; Kurian GA
Naunyn Schmiedebergs Arch Pharmacol; 2021 Oct; 394(10):2103-2115. PubMed ID: 34338837
[TBL] [Abstract][Full Text] [Related]
4. Carbon monoxide induces a late preconditioning-mimetic cardioprotective and antiapoptotic milieu in the myocardium.
Stein AB; Bolli R; Dawn B; Sanganalmath SK; Zhu Y; Wang OL; Guo Y; Motterlini R; Xuan YT
J Mol Cell Cardiol; 2012 Jan; 52(1):228-36. PubMed ID: 22119801
[TBL] [Abstract][Full Text] [Related]
5. Oxygen/ozone protects the heart from acute myocardial infarction through local increase of eNOS activity and endothelial progenitor cells recruitment.
Di Filippo C; Luongo M; Marfella R; Ferraraccio F; Lettieri B; Capuano A; Rossi F; D'Amico M
Naunyn Schmiedebergs Arch Pharmacol; 2010 Sep; 382(3):287-91. PubMed ID: 20694792
[TBL] [Abstract][Full Text] [Related]
6. Beneficial effects of carbon monoxide-releasing molecules on post-ischemic myocardial recovery.
Varadi J; Lekli I; Juhasz B; Bacskay I; Szabo G; Gesztelyi R; Szendrei L; Varga E; Bak I; Foresti R; Motterlini R; Tosaki A
Life Sci; 2007 Apr; 80(17):1619-26. PubMed ID: 17321552
[TBL] [Abstract][Full Text] [Related]
7. Administration of a CO-releasing molecule at the time of reperfusion reduces infarct size in vivo.
Guo Y; Stein AB; Wu WJ; Tan W; Zhu X; Li QH; Dawn B; Motterlini R; Bolli R
Am J Physiol Heart Circ Physiol; 2004 May; 286(5):H1649-53. PubMed ID: 14704226
[TBL] [Abstract][Full Text] [Related]
8. Carbon monoxide releasing molecule improves structural and functional cardiac recovery after myocardial injury.
Segersvärd H; Lakkisto P; Hänninen M; Forsten H; Siren J; Immonen K; Kosonen R; Sarparanta M; Laine M; Tikkanen I
Eur J Pharmacol; 2018 Jan; 818():57-66. PubMed ID: 29055786
[TBL] [Abstract][Full Text] [Related]
9. Carbon monoxide-releasing molecule-2 (CORM-2) attenuates acute hepatic ischemia reperfusion injury in rats.
Wei Y; Chen P; de Bruyn M; Zhang W; Bremer E; Helfrich W
BMC Gastroenterol; 2010 May; 10():42. PubMed ID: 20444253
[TBL] [Abstract][Full Text] [Related]
10. Administration of a CO-releasing molecule induces late preconditioning against myocardial infarction.
Stein AB; Guo Y; Tan W; Wu WJ; Zhu X; Li Q; Luo C; Dawn B; Johnson TR; Motterlini R; Bolli R
J Mol Cell Cardiol; 2005 Jan; 38(1):127-34. PubMed ID: 15623429
[TBL] [Abstract][Full Text] [Related]
11. Effects of carbon monoxide releasing molecule-liberated CO on severe acute pancreatitis in rats.
Chen P; Sun B; Chen H; Wang G; Pan S; Kong R; Bai X; Wang S
Cytokine; 2010 Jan; 49(1):15-23. PubMed ID: 19900821
[TBL] [Abstract][Full Text] [Related]
12. Heme oxygenase-1 and carbon monoxide promote neovascularization after myocardial infarction by modulating the expression of HIF-1alpha, SDF-1alpha and VEGF-B.
Lakkisto P; Kytö V; Forsten H; Siren JM; Segersvärd H; Voipio-Pulkki LM; Laine M; Pulkki K; Tikkanen I
Eur J Pharmacol; 2010 Jun; 635(1-3):156-64. PubMed ID: 20303947
[TBL] [Abstract][Full Text] [Related]
13. Cardioprotective actions by a water-soluble carbon monoxide-releasing molecule.
Clark JE; Naughton P; Shurey S; Green CJ; Johnson TR; Mann BE; Foresti R; Motterlini R
Circ Res; 2003 Jul; 93(2):e2-8. PubMed ID: 12842916
[TBL] [Abstract][Full Text] [Related]
14. 2-methoxycinnamaldehyde from Cinnamomum cassia reduces rat myocardial ischemia and reperfusion injury in vivo due to HO-1 induction.
Hwa JS; Jin YC; Lee YS; Ko YS; Kim YM; Shi LY; Kim HJ; Lee JH; Ngoc TM; Bae KH; Kim YS; Chang KC
J Ethnopharmacol; 2012 Jan; 139(2):605-15. PubMed ID: 22179023
[TBL] [Abstract][Full Text] [Related]
15. Rosuvastatin reduces experimental left ventricular infarct size after ischemia-reperfusion injury but not total coronary occlusion.
Weinberg EO; Scherrer-Crosbie M; Picard MH; Nasseri BA; MacGillivray C; Gannon J; Lian Q; Bloch KD; Lee RT
Am J Physiol Heart Circ Physiol; 2005 Apr; 288(4):H1802-9. PubMed ID: 15563531
[TBL] [Abstract][Full Text] [Related]
16. Cardioprotective effect with carbon monoxide releasing molecule-2 (CORM-2) in isolated perfused rat heart: Role of coronary endothelium and underlying mechanism.
Soni H; Patel P; Rath AC; Jain M; Mehta AA
Vascul Pharmacol; 2010; 53(1-2):68-76. PubMed ID: 20399902
[TBL] [Abstract][Full Text] [Related]
17. Liposomal tetrahydrobiopterin preserves eNOS coupling in the post-ischemic heart conferring in vivo cardioprotection.
Xie L; Talukder MA; Sun J; Varadharaj S; Zweier JL
J Mol Cell Cardiol; 2015 Sep; 86():14-22. PubMed ID: 26116866
[TBL] [Abstract][Full Text] [Related]
18. CORM-2 inhibits intracerebral hemorrhage-mediated inflammation.
Chen Z; Zhang H; Zhou J; Stone C; Ding Y; Zhang Y; Ren C; Yin X; Meng R
Neurol Res; 2021 Oct; 43(10):846-853. PubMed ID: 34107862
[No Abstract] [Full Text] [Related]
19. Oxidative gastric mucosal damage induced by ischemia/reperfusion and the mechanisms of its prevention by carbon monoxide-releasing tricarbonyldichlororuthenium (II) dimer.
Magierowska K; Korbut E; Hubalewska-Mazgaj M; Surmiak M; Chmura A; Bakalarz D; Buszewicz G; Wójcik D; Śliwowski Z; Ginter G; Gromowski T; Kwiecień S; Brzozowski T; Magierowski M
Free Radic Biol Med; 2019 Dec; 145():198-208. PubMed ID: 31568823
[TBL] [Abstract][Full Text] [Related]
20. Ligands of the peroxisome proliferator-activated receptors (PPAR-gamma and PPAR-alpha) reduce myocardial infarct size.
Wayman NS; Hattori Y; McDonald MC; Mota-Filipe H; Cuzzocrea S; Pisano B; Chatterjee PK; Thiemermann C
FASEB J; 2002 Jul; 16(9):1027-40. PubMed ID: 12087064
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
